{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:37Z","timestamp":1792115077936,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/S023054\/1"],"award-info":[{"award-number":["EP\/S023054\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013276","name":"Interreg Europe","doi-asserted-by":"publisher","award":["2S07\\u2013033"],"award-info":[{"award-number":["2S07\\u2013033"]}],"id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["956851"],"award-info":[{"award-number":["956851"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejps.2025.107365","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:05:13Z","timestamp":1762416313000},"page":"107365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8590-3302","authenticated-orcid":false,"given":"Alessia","family":"Favaron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannapat","family":"Sangfuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"McCoubrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atheer","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Ghyselinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Marzorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Verstrepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"De Munck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"De Medts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-6603","authenticated-orcid":false,"given":"Abdul W.","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2047-5025","authenticated-orcid":false,"given":"Mine","family":"Orlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2025.107365_bib0026","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00336-23","article-title":"Machine learning classification by fitting amplicon sequences to existing OTUs","volume":"8","author":"Armour","year":"2023","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.ejps.2025.107365_bib0006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41591-020-01183-8","article-title":"Microbiome connections with host metabolism and habitual diet from 1098 deeply phenotyped individuals","volume":"27","author":"Asnicar","year":"2021","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.ejps.2025.107365_bib0047","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-\u03baB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejps.2025.107365_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114076","article-title":"Clinical translation of advanced colonic drug delivery technologies","volume":"181","author":"Awad","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ejps.2025.107365_bib0008","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00592-011-0333-6","article-title":"Gut microbiota and diabetes: from pathogenesis to therapeutic perspective","volume":"48","author":"Burcelin","year":"2011","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.ejps.2025.107365_bib0027","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jff.2015.11.005","article-title":"Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the simulator of the human intestinal microbial ecosystem","volume":"20","author":"Daguet","year":"2016","journal-title":"J. Funct. Foods"},{"issue":"10","key":"10.1016\/j.ejps.2025.107365_bib0030","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1172\/JCI72330","article-title":"The microbial basis of inflammatory bowel diseases","volume":"124","author":"Dalal","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.ejps.2025.107365_bib0024","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/jn\/130.10.2599","article-title":"Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder","volume":"130","author":"De Boever","year":"2000","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0039","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/microorganisms7010019","article-title":"Microbial fermentation of dietary protein: an important factor in diet\u2013microbe\u2013host interaction","volume":"7","author":"Diether","year":"2019","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrmicro3552","article-title":"Gut biogeography of the bacterial microbiota","volume":"14","author":"Donaldson","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107365_bib0034","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/j.1462-2920.2009.01931.x","article-title":"The role of pH in determining the species composition of the human colonic microbiota","volume":"11","author":"Duncan","year":"2009","journal-title":"Environ. Microbiol."},{"key":"10.1016\/j.ejps.2025.107365_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106845","article-title":"Exploring the interactions of JAK inhibitor and S1P receptor modulator drugs with the human gut microbiome: implications for colonic drug delivery and inflammatory bowel disease","volume":"200","author":"Favaron","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2025.107365_bib0057","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2024.04.024","article-title":"Can in vitro\/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinib","volume":"370","author":"Favaron","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ejps.2025.107365_bib0031","doi-asserted-by":"crossref","first-page":"fiac038","DOI":"10.1093\/femsec\/fiac038","article-title":"The impact of environmental pH on the gut microbiota community structure and short chain fatty acid production","volume":"98","author":"Firrman","year":"2022","journal-title":"FEMS Microbiol. Ecol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107365_bib0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","article-title":"Gut microbiome structure and metabolic activity in inflammatory bowel disease","volume":"4","author":"Franzosa","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107365_bib0037","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.3390\/ijms22063061","article-title":"Butyrate and the fine-tuning of colonic homeostasis: implication for inflammatory bowel diseases","volume":"22","author":"Gasaly","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107365_bib0023","article-title":"Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson\u2019s disease","volume":"3","author":"Ghyselinck","year":"2021","journal-title":"Int. J. Pharm. X"},{"issue":"4","key":"10.1016\/j.ejps.2025.107365_bib0022","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.resmic.2013.01.007","article-title":"Efficient cryopreservation protocol enables accessibility of a broad range of ammonia-oxidizing bacteria for the scientific community","volume":"164","author":"Hoefman","year":"2013","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.ejps.2025.107365_bib0040","article-title":"Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn\u2019s disease","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0029","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13059-021-02368-1","article-title":"TreeclimbR pinpoints the data-dependent resolution of hierarchical hypotheses","volume":"22","author":"Huang","year":"2021","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107365_bib0009","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/pathogens8030126","article-title":"Alteration of gut microbiota in inflammatory bowel disease (IBD): cause or consequence? ibd treatment targeting the gut microbiome","volume":"8","author":"Khan","year":"2019","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0036","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11938-019-00221-w","article-title":"The gut microbiome as a target for IBD treatment: are we there yet?","volume":"17","author":"Knox","year":"2019","journal-title":"Curr. Treat. Options Gastroenterol."},{"issue":"20","key":"10.1016\/j.ejps.2025.107365_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012445","article-title":"Etiology of IBD\u2014is it still a mystery?","volume":"23","author":"Kofla-D\u0142ubacz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2025.107365_bib0054","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7758","key":"10.1016\/j.ejps.2025.107365_bib0012","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejps.2025.107365_bib0033","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1462-2920.2009.02066.x","article-title":"Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene","volume":"12","author":"Louis","year":"2010","journal-title":"Environ. Microbiol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0032","first-page":"57","article-title":"Comparison of fermentation reactions in different regions of the human colon","volume":"72","author":"Macfarlane","year":"1992","journal-title":"J. Appl. Bacteriol."},{"key":"10.1016\/j.ejps.2025.107365_bib0003","first-page":"1","article-title":"The gut microbiota and its biogeography","author":"McCallum","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejps.2025.107365_bib0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jconrel.2022.12.029","article-title":"Colonic drug delivery: formulating the next generation of colon-targeted therapeutics","volume":"353","author":"McCoubrey","year":"2023","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejps.2025.107365_bib0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","article-title":"Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity","volume":"7","author":"Mills","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0007","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41577-022-00727-y","article-title":"The impact of the gut microbiome on extra-intestinal autoimmune diseases","volume":"23","author":"Miyauchi","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.ejps.2025.107365_bib0011","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/gb-2012-13-9-r79","article-title":"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment","volume":"13","author":"Morgan","year":"2012","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107365_bib0049","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/ibd.20148","article-title":"Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance","volume":"13","author":"Mudter","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"6086","key":"10.1016\/j.ejps.2025.107365_bib0005","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejps.2025.107365_bib0014","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/0897190020953019","article-title":"Tofacitinib, the first oral janus kinase inhibitor approved for adult ulcerative colitis","volume":"34","author":"Palasik","year":"2021","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.ejps.2025.107365_bib0035","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front. Immunol. [Internet]"},{"issue":"19","key":"10.1016\/j.ejps.2025.107365_bib0045","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.3390\/nu15194229","article-title":"Ex vivo colonic fermentation of NUTRIOSE\u00ae exerts immuno-modulatory properties and strong anti-inflammatory effects","volume":"15","author":"Perreau","year":"2023","journal-title":"Nutrients"},{"issue":"5\u20136","key":"10.1016\/j.ejps.2025.107365_bib0041","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1615\/CritRevImmunol.v23.i56.20","article-title":"Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development","volume":"23","author":"Phalipon","year":"2003","journal-title":"Crit. Rev. Immunol."},{"issue":"39","key":"10.1016\/j.ejps.2025.107365_bib0028","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1021\/jf402137r","article-title":"A dried yeast fermentate selectively modulates both the luminal and mucosal gut microbiota and protects against inflammation, as studied in an integrated in vitro approach","volume":"61","author":"Possemiers","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejps.2025.107365_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127336","article-title":"In vitro models to study human gut-microbiota interactions: applications, advances, and limitations","volume":"270","author":"Qi","year":"2023","journal-title":"Microbiol. Res."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ejps.2025.107365_bib0018","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.trsl.2025.02.004","article-title":"Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn\u2019s disease: a pilot study","volume":"278","author":"Sangfuang","year":"2025","journal-title":"Transl. Res."},{"issue":"19","key":"10.1016\/j.ejps.2025.107365_bib0020","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.yexcr.2006.08.018","article-title":"Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha","volume":"312","author":"Satsu","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.ejps.2025.107365_bib0048","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"10.1016\/j.ejps.2025.107365_bib0053","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine"},{"issue":"18","key":"10.1016\/j.ejps.2025.107365_bib0052","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3748\/wjg.v29.i18.2733","article-title":"Study of tumor necrosis factor receptor in the inflammatory bowel disease","volume":"29","author":"Souza","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107365_bib0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcmgh.2021.09.004","article-title":"Tofacitinib-induced modulation of intestinal adaptive and innate immunity and factors driving cellular and systemic pharmacokinetics","volume":"13","author":"Texler","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.ejps.2025.107365_bib0056","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/ajg.2014.246","article-title":"Antibiotics associated with increased risk of new-onset Crohn\u2019s disease but not ulcerative colitis: a meta-analysis","volume":"109","author":"Ungaro","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107365_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.femsec.2004.07.014","article-title":"Prebiotic effects of chicory inulin in the simulator of the human intestinal microbial ecosystem","volume":"51","author":"Van de Wiele","year":"2004","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.ejps.2025.107365_bib0019","series-title":"The Impact of Food Bioactives On Health: in Vitro and Ex Vivo Models [Internet]","article-title":"The simulator of the human intestinal microbial ecosystem (SHIME\u00ae)","author":"Van de Wiele","year":"2015"},{"issue":"7681","key":"10.1016\/j.ejps.2025.107365_bib0043","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2025.107365_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.anaerobe.2017.01.001","article-title":"The role of gut microbiota in health and disease: in vitro modeling of host-microbe interactions at the aerobe-anaerobe interphase of the human gut","volume":"44","author":"von Martels","year":"2017","journal-title":"Anaerobe"},{"issue":"8","key":"10.1016\/j.ejps.2025.107365_bib0001","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41564-023-01426-7","article-title":"Human microbiome myths and misconceptions","volume":"8","author":"Walker","year":"2023","journal-title":"Nat. Microbiol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107365_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00645-20","article-title":"Pivotal Roles for pH, lactate, and lactate-utilizing bacteria in the stability of a human colonic microbial ecosystem","volume":"5","author":"Wang","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.ejps.2025.107365_bib0021","unstructured":"XELJANZ \/XELJANZ X.R. (Tofacitinib) Description | Pfizer Medical Information - US [Internet]. [cited 2024 Aug 21]. Available from: https:\/\/www.pfizermedicalinformation.com\/xeljanz\/description."},{"key":"10.1016\/j.ejps.2025.107365_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOG.0000000000001064","article-title":"Advances in colon-targeted drug technologies","volume":"41","author":"Yeung","year":"2025","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"8007","key":"10.1016\/j.ejps.2025.107365_bib0042","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-024-07182-w","article-title":"A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche","volume":"628","author":"Zepeda-Rivera","year":"2024","journal-title":"Nature"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725003628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:52:50Z","timestamp":1773330770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725003628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":58,"alternative-id":["S0928098725003628"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107365","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the effects of tofacitinib on the gut microbiome in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107365"}}